Recovery & Side Effects
Post-inflammatory Hyperpigmentation
Post-inflammatory hyperpigmentation is a brown-gray discoloration that occurs due to increased melanin production after inflammation or damage to the skin.
Dr. Hamza Gemici
Medical Doctor — Medical Aesthetics Physician
Review date:
In short: Post-inflammatory hyperpigmentation is a brown-gray discoloration that occurs due to increased melanin production after inflammation or damage to the skin. Risk varies with skin tone, treatment depth, energy setting, sun exposure, and history of inflammation.
Definition
Post-inflammatory Hyperpigmentation is an important decision and safety concept that patients may encounter before or after a procedure. Post-inflammatory hyperpigmentation is a brown-gray discoloration that occurs due to increased melanin production after inflammation or damage to the skin.
Risk varies with skin tone, treatment depth, energy setting, sun exposure, and history of inflammation. Therefore, the concept should be evaluated not through a single product name or social media claim, but by considering examination, current product-device information, medical history, and follow-up opportunities together.
How It Is Applied
Evaluation begins by recording when the patient's complaint started, which procedure or product it is associated with, and how the symptoms have changed. The physician examines the target area at rest and in motion; obtains information about previous procedures, illnesses, medications, allergies, and recent health events.
Skin type, tan, previous PIH history, medications used, and sun protection capacity should be recorded before the procedure. If necessary, photographs, product labels, device-parameter records, ultrasound, or another specialist's opinion may be part of the plan. Each of these tools supports clinical evaluation; none alone aims to support diagnosis or zero risk.
Indications
The title Post-inflammatory Hyperpigmentation gains meaning especially when planning a new procedure, investigating why a previous result was different, or classifying an unexpected symptom. The goal is not to apply the same test or treatment to everyone, but to determine which patient requires additional evaluation.
- Lack of information about previous procedure, product, or device
- A timeline different from expected healing
- Recurrent, progressive, or asymmetric findings
- High-risk anatomical area or significant comorbidity
Contraindications
The existence of this concept does not directly mean that a new procedure should be performed. Active infection, unexplained skin lesion, unrealistic expectations, incomplete product records, or lack of follow-up in case of complications may require postponing the procedure and first diagnostic evaluation.
Pregnancy, breastfeeding, immune system diseases, bleeding disorders, and medications used are evaluated separately according to the type of procedure. Prescription medications should not be discontinued based solely on internet content.
Duration of Effect and Recovery
Darkening may decrease within weeks-months, but the duration varies from person to person, and not all pigment changes are the same. Swelling, tenderness, redness, and the time it takes for the result to settle may differ in two people undergoing the same procedure. The clinic should explain the expected course before the procedure and determine the control time according to personal risks.
When evaluating recovery, not just a single photograph, but the initial image, changes in symptoms over hours-days, pain severity, and accompanying systemic symptoms are considered together. Early communication often reduces uncertainty.
Risks and Side Effects
In the early period, aggressive actives or uncontrolled additional procedures can increase barrier damage and pigment. Although the most common effects in medical aesthetics are usually temporary redness, tenderness, swelling, or bruising, rarer, serious complications specific to products and devices are also possible.
Blistering, open wounds, increased pain, pus, sharply demarcated whitening, or rapid worsening require evaluation. The patient should be informed in writing about which symptoms are sufficient to send a photo, in which case an examination is required on the same day, and in which case emergency medical services should be sought.
Comparison
| Title | Approach that is not sufficient alone | Safer approach |
|---|---|---|
| Diagnosis | Single photo or single symptom | History, examination, timeline, and imaging if necessary |
| Risk | Statement “There is no risk in this procedure” | Explanation of probability, severity, early symptoms, and management plan |
| Follow-up | Waiting if symptoms occur | Pre-determined control and emergency communication channel |
Alternatives and Combination Treatments
Post-inflammatory Hyperpigmentation is not a treatment brand. Alternatives sometimes include postponing the procedure, first ruling out another diagnosis, changing the current product or device, choosing a more conservative plan, or not performing any procedure at all. Combination decisions should be sequenced to allow time for tissue healing.
Adding multiple methods simultaneously does not always yield better results. The purpose of each step, its expected contribution, uncertainty, and how it affects subsequent evaluation should be discussed separately.
Related Terms
Frequently Asked Questions
Why does darkening occur after the procedure? The answer depends on personal examination. Risk varies with skin tone, treatment depth, energy setting, sun exposure, and history of inflammation.
Does a single test or tool completely eliminate risk? No. Safety relies on the combined application of correct patient selection, anatomical knowledge, appropriate product-device, controlled technique, record-keeping, and complication preparedness.
Dr. Hamza Gemici's Comment
“The most valuable approach to Post-inflammatory Hyperpigmentation is not to magnify or belittle a single finding, but to read the timeline, anatomy, and the patient's entire health history together.”
Dr. Hamza Gemici
Sources and References
This content has been prepared for patient education purposes based on official regulatory information and peer-reviewed publications. It is not personal diagnostic or treatment instruction.
- Microneedling Devices — U.S. Food and Drug Administration (2025)
- Potential Risks with Certain Uses of Radiofrequency (RF) Microneedling — U.S. Food and Drug Administration (2025)
Last medical review: July 26, 2026 · Medical editor: Dr. Hamza Gemici
Frequently Asked Questions
Risk varies with skin tone, treatment depth, energy setting, sun exposure, and history of inflammation. For a personal answer, physician evaluation is required along with the procedure and health history.
In the early period, aggressive actives or uncontrolled additional procedures can increase barrier damage and pigment.
Blistering, open wounds, increased pain, pus, sharply demarcated whitening, or rapid worsening require evaluation.
Skin type, tan, previous PIH history, medications used, and sun protection capacity should be recorded before the procedure.
Sources and References
This content draws on the scientific publications, regulatory documents and professional sources listed below and was medically reviewed by Dr. Hamza Gemici.
- 1.Kaufman BP, Aman T, Alexis AF. Postinflammatory Hyperpigmentation: Epidemiology, Clinical Presentation, Pathogenesis and Treatment. (2018) — American journal of clinical dermatologyOpen source
- 2.Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. (2010) — The Journal of clinical and aesthetic dermatologyOpen source
- 3.Tan MG, Kim WB, Jo CE, et al.. Topical treatment for postinflammatory hyperpigmentation: a systematic review. (2022) — The Journal of dermatological treatmentOpen source
- 4.Agbai O, Hamzavi I, Jagdeo J. Laser Treatments for Postinflammatory Hyperpigmentation: A Systematic Review. (2017) — JAMA dermatologyOpen source
- 5.Wongdama S, Yenyuwadee S, Li JB, et al.. Interventions to Prevent Postinflammatory Hyperpigmentation After Laser and Energy-Based Device Treatments: A Systematic Review and Network Meta-Analysis. (2026) — Lasers in surgery and medicineOpen source
- 6.Cheyasak N, Manuskiatti W, Maneeprasopchoke P, et al.. Topical corticosteroids minimise the risk of postinflammatory hyper-pigmentation after ablative fractional CO2 laser resurfacing in Asians. (2015) — Acta dermato-venereologicaOpen source
- 7.West TB, Alster TS. Effect of pretreatment on the incidence of hyperpigmentation following cutaneous CO2 laser resurfacing. (1999) — Dermatologic surgeryOpen source
- 8.Chan HH, Manstein D, Yu CS, et al.. The prevalence and risk factors of post-inflammatory hyperpigmentation after fractional resurfacing in Asians. (2007) — Lasers in surgery and medicineOpen source
Book an appointment for Post-inflammatory Hyperpigmentation?
Schedule a physician assessment with Dr. Hamza Gemici.
Book Now